The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Investigators conducted a systematic review and meta-analysis to elucidate the efficacy and safety of cTBS for the treatment of auditory hallucinations in schizophrenia.

Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...

The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major advancement in schizophrenia treatment in decades. Unlike existing medications that ...

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.

Millions of Americans are affected by psychosis, a condition that includes schizophrenia, bipolar disorder, and depression.

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

The conference also served to educate the attendees about UAMS' Odyssey Clinic. Dr. Craig Jones, the clinic's program manager, said it opened July 1 and works with schizophrenia patients 16 years or ...

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...